Your browser doesn't support javascript.
loading
STOP-HF Trial: Higher Endogenous BNP and Cardiovascular Protection in Subjects at Risk for Heart Failure.
Cannone, Valentina; Ledwidge, Mark; Watson, Chris; McKie, Paul M; Burnett, John C; McDonald, Kenneth.
Affiliation
  • Cannone V; Cardiorenal Research Laboratory, Division of Circulatory Failure, Department of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota, USA.
  • Ledwidge M; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Watson C; STOP-HF Unit, St Vincent's University Healthcare Group, Dublin, Ireland.
  • McKie PM; School of Medicine, University College Dublin, Dublin, Ireland.
  • Burnett JC; UCD Conway Institute, School of Medicine, University College Dublin, Dublin, Ireland.
  • McDonald K; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, Northern Ireland.
JACC Basic Transl Sci ; 6(6): 497-504, 2021 Jun.
Article in En | MEDLINE | ID: mdl-34222720
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: JACC Basic Transl Sci Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: JACC Basic Transl Sci Year: 2021 Document type: Article Affiliation country: Country of publication: